The JAK-STAT signaling pathway is differentially activated in CALR-positive compared with JAK2V617F-positive ET patients

被引：34
|
作者：
Lau, Winnie W. Y. [1 ,2 ,3 ]
Hannah, Rebecca [1 ,2 ,3 ]
Green, Anthony R. [1 ,2 ,3 ,4 ]
Goettgens, Bertie [1 ,2 ,3 ]
机构：
[1] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England
[2] Univ Cambridge, Wellcome Trust, Stem Cell Inst, Med Res Council, Cambridge, England
[3] Univ Cambridge, Dept Haematol, Cambridge, England
[4] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 2QQ, England
来源：
BLOOD | 2015年 / 125卷 / 10期
基金：
英国惠康基金; 英国生物技术与生命科学研究理事会; 英国医学研究理事会;
关键词：
MYELOPROLIFERATIVE NEOPLASMS; ENRICHMENT ANALYSIS; MUTATIONS; CELLS;
D O I：
10.1182/blood-2014-12-618074
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1679 / 1681
页数：3
相关论文
共 50 条
  • [31] Concomitant and noncanonical JAK2 and MPL mutations in JAK2V617F-and MPLW515 L-positive myelofibrosis
    Schulze, Susann
    Stengel, Rayk
    Jaekel, Nadja
    Wang, Song-Yau
    Franke, Georg-Nikolaus
    Roskos, Martin
    Schneider, Melanie
    Niederwieser, Dietger
    Al-Ali, Haifa Kathrin
    GENES CHROMOSOMES & CANCER, 2019, 58 (11) : 747 - 755
  • [32] Estimation of diagnosis and prognosis in ET by assessment of CALR and JAK2V617F mutations and laboratory findings: a meta-analysis
    Saki, N.
    Shirzad, R.
    Rahim, F.
    Malehi, A. Saki
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (07) : 874 - 883
  • [33] The relevance of HLA class II genes in JAK2 V617F-positive myeloproliferative neoplasms
    Shivarov, Velizar
    Tsvetkova, Gergana
    Hadjiev, Evgueniy
    Ivanova, Milena
    HUMAN IMMUNOLOGY, 2023, 84 (03) : 199 - 207
  • [34] Interferon Apha 2b for Treating Patients with JAK2V617F Positive Polycythemia Vera and Essential Thrombocytosis
    Zhang, Zhi-Rong
    Duan, Yan-Chao
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (04) : 1681 - 1684
  • [35] Aspirin-Responsive, Migraine-Like Transient Cerebral and Ocular Ischemic Attacks and Erythromelalgia in JAK2V617F-Positive Essential Thrombocythemia and Polycythemia Vera
    Michiels, Jan Jacques
    Berneman, Zwi
    Gadisseur, Alain
    Lam, King H.
    De Raeve, Hendrik
    Schroyens, Wilfried
    ACTA HAEMATOLOGICA, 2015, 133 (01) : 56 - 63
  • [36] Frequency of JAK2V617F and CALR somatic mutations in Egyptian patients with thrombocytosis: relation with clinical and hematological phenotype
    Hamed, Gehan Mostafa
    Abdelmaksoud, Mariam Fathy
    Abdulrahman, Doha Osama
    El Sakhawy, Yasmin Nabil
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2022, 47 (03) : 167 - 173
  • [37] A comprehensive genome-wide analysis of long non-coding RNA and mRNA expression profiles of JAK2V617F-positive classical myeloproliferative neoplasms
    Zhou, Jie
    Wu, Hao
    Guo, Cheng
    Li, Bing
    Zhou, Li-Li
    Liang, Ai-Bin
    Fu, Jian-Fei
    BIOENGINEERED, 2021, 12 (02) : 10564 - 10586
  • [38] Differential roles of STAT1 and STAT2 in the sensitivity of JAK2V617F-vs. BCR-ABL-positive cells to interferon alpha
    Schubert, Claudia
    Allhoff, Manuel
    Tillmann, Stefan
    Maie, Tiago
    Costa, Ivan G.
    Lipka, Daniel B.
    Schemionek, Mirle
    Feldberg, Kristina
    Baumeister, Julian
    Bruemmendorf, Tim H.
    Chatain, Nicolas
    Koschmieder, Steffen
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
  • [39] PROJECT ASSESSMENT OF THE FAK/SRC PATHWAY ROLE IN THE PROLIFERATION AND APOPTOSIS OF JAK2 V617F POSITIVE CELL LINE.
    Menezes Mendonca Valente, Ana Carolina
    Ribeiro, Raquel Tognon
    BIOPHYSICAL REVIEWS, 2021, 13 (06) : 1445 - 1445
  • [40] THE POSSIBLE ASSOCIATION OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE AND JAK2-V617F POSITIVE CHRONIC MYELOPROLIFERATIVE NEOPLASM
    Valkovic, Toni
    ACTA CLINICA CROATICA, 2014, 53 (02) : 256 - 257
12345